Role of inositol-1,4,5-trisphosphate receptor in the regulation of calcium transients in neonatal rat ventricular myocytes

Journal of Pharmacological Sciences

Volumn 126, Issue 1, 2014, Pages 37-46

  Zeng, Zheng ^a,b   Zhang, Heping ^c   Lin, Na ^d   Kang, Man ^a,b   Zheng, Yuanyuan ^a,b   Li, Chen ^a,b   Xu, Pingxiang ^a,b   Wu, Yongquan ^c   Luo, Dali ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Key Laboratory of Metabolic Disturbance Related Cardiovascular Disease   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d PEKING UNIVERSITY   (China)

Author keywords

Ca2+ transient; Gap junction; Inositol 1,4,5 trisphosphate receptor; Ryanodine receptor; Ventricular myocyte

Indexed keywords

CALCIUM ION; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PHENYLEPHRINE; RYANODINE; RYANODINE RECEPTOR; SHORT HAIRPIN RNA; TETRACAINE; CALCIUM;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL DENSITY; CELL MEMBRANE PERMEABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GAP JUNCTION; HEART MUSCLE CELL; INTRACELLULAR SIGNALING; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; ANIMAL; CELL CULTURE; CYTOLOGY; HEART VENTRICLE; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL TRANSPORT; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; GAP JUNCTIONS; HEART VENTRICLES; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MYOCYTES, CARDIAC; RATS; RYANODINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 84909943174     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.14029FP     Document Type: Article

References (31)

1. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Rev Mol Cell Biol. 2000;1:11-21.
2. Uhlén P, Fritz N. Biochemistry of calcium oscillations. Biochem Biophys Res Commun. 2010;396:28-32.
3. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol. 2008;70:23-49.
4. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415:198-205.
5. Maltsev VA, Vinogradova TM, Lakatta EG. The emergence of a general theory of the initiation and strength of the heartbeat. J Pharmacol Sci. 2005;100:338-369.
6. 2+ signaling in intact myocardium. J Pharmacol Sci. 2005;100:525-537.
7. 2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest. 2006;116:675-682.
8. 2+ sparks and waves mediated by inositol 1,4,5-trisphosphate receptors in neonatal rat cardiomyocytes. Cell Calcium. 2008;43:165-174.
9. Ibarra C, Estrada M, Carrasco L, Chiong M, Liberona JL, Cardenas C, et al. Insulin-like growth factor-1 induces an inositol 1,4,5-trisphosphate-dependent increase in nuclear and cytosolic calcium in cultured rat cardiac myocytes. J Biol Chem. 2004;279:7554-7565.
10. Ju YK, Liu J, Lee BH, Lai D, Woodcock EA, Lei M, et al. Distribution and functional role of inositol 1,4,5-trisphosphate receptors in mouse sinoatrial node. Circ Res. 2011;109:848-857.
11. 3 generation and arrhythmias in hearts expressing constitutively active α1β-adrenergic receptors. Circ Res. 1998;83:1232-1240.
12. 2+ signalling in cat atrial excitation-contraction coupling and arrhythmias. J Physiol. 2004;555:607-615.
13. 2+ signaling in rat ventricular myocytes. PLoS One. 2012;7:e36165.
14. Kijima Y, Saito A, Jetton T, Magnuson M, Fleischer S. Different intracellular localization of inositol 1,4,5-trisphosphate and ryanodine receptors in cardiomyocytes. J Biol Chem. 1993;268:3499-3506.
15. 2+ communication. J Cell Sci. 2008;121:3664-3673.
16. Li W, Schultz C, Llopis J, Tsien RY. Membrane-permeant esters of inositol polyphosphates, chemical syntheses and biological applications. Tetrahedron. 1997;53:12017-12040.
17. i in rabbit ventricular myocytes during metabolic inhibition. J Mol Cell Cardiol. 2001;33:2145-2155.
18. Signore S, Sorrentino A, Ferreira-Martins J, Kannappan R, Shafaie M, Del Ben F, et al. Inositol 1,4,5-trisphosphate receptors and human left ventricular myocytes. Circulation. 2013;128:1286-1297.
19. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Rev Mol Cell Biol. 2003;4:517-529.
20. 2+ release modulates excitation-contraction coupling in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol. 2008;294:H596-H604.
21. Bezprozvanny I. The inositol 1,4,5-trisphosphate receptors. Cell Calcium. 2005;38:261-272.
22. Kockskämper J, Zima AV, Roderick HL, Pieske B, Blatter LA, Bootman MD. Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes. J Mol Cell Cardiol. 2008;45: 128-147.
23. 2+ stores. Am J Physiol Heart Circ Physiol. 2010;298:H1939-H1950.
24. Giepmans BN. Gap junctions and connexin-interacting proteins. Cardiovasc Res. 2004;62:233-245.
25. Laird D. Life cycle of connexins in health and disease. Biochem J. 2006;394:527-543.
26. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breitbach M, et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature. 2007;450:819-824.
27. Dhein S. Cardiac ischemia and uncoupling: gap junctions in ischemia and infarction. Adv Cardiol. 2006;42:198-212.
28. Severs NJ, Bruce AF, Dupont E, Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res. 2008;80:9-19.
29. Woodcock EA, Reyes N, Jacobsen AN, Du XJ. Inhibition of inositol (1,4,5) trisphosphate generation by endothelin-1 during postischemic reperfusion a novel antiarrhythmic mechanism. Circulation. 1999;99:823-828.
30. 3 receptor regulates cardiac hypertrophy in response to select stimuli. Circ Res. 2010;107:659-666.
31. 3 release. Circulation. 1995;91:2712-2716.